Julien Blouin

Stock Analyst at Goldman Sachs

(2.39)
# 3,123
Out of 5,182 analysts
28
Total ratings
52.38%
Success rate
0.25%
Average return

Stocks Rated by Julien Blouin

UDR, Inc.
Jan 20, 2026
Maintains: Sell
Price Target: $33$38
Current: $35.11
Upside: +6.81%
Healthpeak Properties
Jan 9, 2026
Initiates: Neutral
Price Target: $17
Current: $16.74
Upside: +1.55%
Jones Lang LaSalle
Nov 26, 2025
Maintains: Buy
Price Target: $361$407
Current: $317.74
Upside: +28.09%
Camden Property Trust
Sep 17, 2025
Downgrades: Sell
Price Target: $118$106
Current: $101.95
Upside: +3.97%
American Homes 4 Rent
Sep 17, 2025
Downgrades: Neutral
Price Target: $43$37
Current: $29.76
Upside: +24.33%
Cushman & Wakefield
Aug 13, 2025
Maintains: Buy
Price Target: $18$20
Current: $13.22
Upside: +51.29%
Millrose Properties
May 15, 2025
Maintains: Buy
Price Target: $28$32
Current: $30.57
Upside: +3.04%
Invitation Homes
May 6, 2025
Maintains: Buy
Price Target: $39$43
Current: $26.02
Upside: +65.26%
Newmark Group
Mar 19, 2025
Maintains: Buy
Price Target: $20$17
Current: $15.15
Upside: +12.21%
Colliers International Group
Mar 19, 2025
Maintains: Neutral
Price Target: $165$145
Current: $111.15
Upside: +30.45%
Initiates: Buy
Price Target: $176
Current: $141.22
Upside: +24.63%
Initiates: Neutral
Price Target: $318
Current: $250.07
Upside: +27.16%
Initiates: Neutral
Price Target: $81
Current: $61.14
Upside: +32.48%
Initiates: Buy
Price Target: $187
Current: $126.39
Upside: +47.95%